Gunnar Esiason, MBA, MPH

VP of Patient Strategy and Innovation

Gunnar Esiason is the Vice President of Patient Strategy and Innovation at Raven. Gunnar is a cystic fibrosis and rare disease patient leader, who is passionate about early-stage drug development, patient empowerment, and health policy. Professionally, he is an accomplished patient advocate who has also developed a patient engagement platform for a medical nutrition company, built a venture philanthropy practice at the Boomer Esiason Foundation. Gunnar has consulted on clinical trial development, a real-world evidence population health study, and a cystic fibrosis-specific mental health and wellness screening tool. Gunnar’s health policy opinions have been featured in the Wall Street Journal, USA Today, The Hill, and STAT News. Gunnar holds a MBA from the Tuck School of Business at Dartmouth, where he was a Wilson Scholar and received the Julia Stell Award, a MPH from the Dartmouth Institute for Health Policy & Clinical Practice, and a BA from Boston College.